Investing.com - In8bio reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that was inline with expectations.
In8bio announced earnings per share of $-0.34 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.30 on revenue of $0.00.
In8bio shares are down 4.96% from the beginning of the year , still down 81.78% from its 52 week high of $8.89 set on Monday, November 15, 2021.
In8bio shares gained 0.93% in intra-day trade the report.
In8bio follows other major Healthcare sector earnings this month
In8bio's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar